“…In a pilot (n ϭ 78) open-label, single-center, randomized controlled trial among critically ill patients requiring RRT, Hermite et al (5) reported a significantly longer time for central catheter-associated bloodstream infection (CLABSI) (6) to occur in the citrate locking group (20 days versus 14 days in the saline solution locking group; hazard ratio [HR], 2.8; 95% confidence interval [CI], 1.0 to 7.6; P ϭ 0.04). Of note, the incidence of CLABSI in this study (5) was Ͼ24 per 1,000 catheter-days and contrasts with the incidence of CRBSI found in the multicenter Cathedia cohort (1.9 per 1,000 catheterdays) (7) and in the study by Skofic et al (8) conducted using the same type of patients (1.6 per 1,000 catheter-days). Whether citrate lock is more effective than saline solution or heparin lock in intensive care unit (ICU) settings and whether it is associated with a lower incidence of CRBSI remain unclear (9).…”